Head of Investor Relations
Ptc Therapeutics, Inc. (PTCT)Equibles does not estimate personal net worth.
Get an email with a short summary when Ptc Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get PTCT alertsRon Aldridge is recorded as Head of Investor Relations at Ptc Therapeutics, Inc. (PTCT). Ron Aldridge has spoken on 2 earnings calls across 1 company, most recently for Ptc Therapeutics, Inc. on August 8, 2024. Ptc Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Ptc Therapeutics, Inc. includes Dr. Matthew B. Klein (CEO and Board Member), Matthew B. Klein (CEO and Board Member), Matthew Klein (CEO and Board Member) and 7 others.
“Good afternoon and thank you for joining us today to discuss PTC Therapeutics second quarter 2024 corporate update and financial results.”
“Good afternoon and thank you for joining us today to discuss PTC Therapeutics' fourth quarter and full year 2023 corporate update and financial results.”
Biotechnology · Healthcare
Head of Investor Relations
